Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only curative option for many nonmalignant hematopoietic-derived diseases in pediatric patients. Survival after HSCT has improved in recent years and resulted in a 90% survival rate and cure in some nonmalignant diseases. Graft-vs.-ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaidman, Irina, Even-Or, Ehud, Aharoni, Elroee, Averbuch, Dina, Dinur-Schejter, Yael, NaserEddin, Adeeb, Slae, Mordechai, Shadur, Bella, Stepensky, Polina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250657/
https://www.ncbi.nlm.nih.gov/pubmed/37303759
http://dx.doi.org/10.3389/fped.2023.1194891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250657/
https://www.ncbi.nlm.nih.gov/pubmed/37303759
http://dx.doi.org/10.3389/fped.2023.1194891

Ejemplares similares